These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 18571393)

  • 1. Is fasting glucose variability a risk factor for retinopathy in people with type 2 diabetes?
    Zoppini G; Verlato G; Targher G; Casati S; Gusson E; Biasi V; Perrone F; Bonora E; Muggeo M
    Nutr Metab Cardiovasc Dis; 2009 Jun; 19(5):334-9. PubMed ID: 18571393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasting plasma glucose variability as a risk factor of retinopathy in Type 2 diabetic patients.
    Gimeno-Orna JA; Castro-Alonso FJ; Boned-Juliani B; Lou-Arnal LM
    J Diabetes Complications; 2003; 17(2):78-81. PubMed ID: 12614973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes diagnostic thresholds of the glycated hemoglobin A1c and fasting plasma glucose levels considering the 5-year incidence of retinopathy.
    Nakagami T; Takahashi K; Suto C; Oya J; Tanaka Y; Kurita M; Isago C; Hasegawa Y; Ito A; Uchigata Y
    Diabetes Res Clin Pract; 2017 Feb; 124():20-29. PubMed ID: 28081449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasting plasma glucose variability levels and risk of adverse outcomes among patients with type 2 diabetes: A systematic review and meta-analysis.
    Zhao Q; Zhou F; Zhang Y; Zhou X; Ying C
    Diabetes Res Clin Pract; 2019 Feb; 148():23-31. PubMed ID: 30583033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal cutoff values of fasting plasma glucose (FPG) variability for detecting retinopathy and the threshold of FPG levels for predicting the risk of retinopathy in type 2 diabetes: A longitudinal study over 27 years.
    Takao T; Inoue K; Suka M; Yanagisawa H; Iwamoto Y
    Diabetes Res Clin Pract; 2018 Jun; 140():228-235. PubMed ID: 29625141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of fasting plasma glucose variability and time-dependent glycemic control on the long-term risk of retinopathy in type 2 diabetic patients.
    Takao T; Ide T; Yanagisawa H; Kikuchi M; Kawazu S; Matsuyama Y
    Diabetes Res Clin Pract; 2011 Feb; 91(2):e40-2. PubMed ID: 21035886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison in the ability to detect diabetic retinopathy between fasting plasma glucose and HbA1c levels in a longitudinal study.
    Matsushita Y; Yokoyama T; Takeda N; Katai N; Yoshida-Hata N; Nakamura Y; Yamamoto S; Noda M; Mizoue T; Nakagawa T
    Endocrinol Diabetes Metab; 2021 Jan; 4(1):e00196. PubMed ID: 33532623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycated haemoglobin, plasma glucose and diabetic retinopathy: cross-sectional and prospective analyses.
    Liu QZ; Pettitt DJ; Hanson RL; Charles MA; Klein R; Bennett PH; Knowler WC
    Diabetologia; 1993 May; 36(5):428-32. PubMed ID: 8314447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
    Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L
    Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of fasting plasma glucose variability on the risk of retinopathy in type 2 diabetic patients: retrospective long-term follow-up.
    Takao T; Ide T; Yanagisawa H; Kikuchi M; Kawazu S; Matsuyama Y
    Diabetes Res Clin Pract; 2010 Sep; 89(3):296-302. PubMed ID: 20416966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study.
    Muggeo M; Zoppini G; Bonora E; Brun E; Bonadonna RC; Moghetti P; Verlato G
    Diabetes Care; 2000 Jan; 23(1):45-50. PubMed ID: 10857967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycaemic and haemoglobin A1c thresholds for detecting diabetic retinopathy: the fifth Korea National Health and Nutrition Examination Survey (2011).
    Park YM; Ko SH; Lee JM; Kim DJ; Kim DJ; Han K; Bower JK; Ahn YB;
    Diabetes Res Clin Pract; 2014 Jun; 104(3):435-42. PubMed ID: 24785739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term instability of fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with non-insulin-dependent diabetes mellitus: the Verona Diabetes Study.
    Muggeo M; Verlato G; Bonora E; Zoppini G; Corbellini M; de Marco R
    Circulation; 1997 Sep; 96(6):1750-4. PubMed ID: 9323057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and progression of diabetic retinopathy among non-insulin-dependent diabetic subjects: a 4-year follow-up.
    Chen MS; Kao CS; Fu CC; Chen CJ; Tai TY
    Int J Epidemiol; 1995 Aug; 24(4):787-95. PubMed ID: 8550277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between Clinical Features of Diabetic Retinopathy and Systemic Factors in Patients with Newly Diagnosed Type II Diabetes Mellitus.
    Hwang H; Kim JY; Oh TK; Chae JB; Kim DY
    J Korean Med Sci; 2020 Jun; 35(23):e179. PubMed ID: 32537951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes.
    Suguro T; Watanabe T; Kodate S; Xu G; Hirano T; Adachi M; Miyazaki A
    Clin Sci (Lond); 2008 Dec; 115(11):327-34. PubMed ID: 18338983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Accuracy of Diagnostic Methods for Diabetic Retinopathy: A Systematic Review and Meta-Analysis.
    Martínez-Vizcaíno V; Cavero-Redondo I; Álvarez-Bueno C; Rodríguez-Artalejo F
    PLoS One; 2016; 11(4):e0154411. PubMed ID: 27123641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemoglobin A1c and fasting plasma glucose levels as predictors of retinopathy at 10 years: the French DESIR study.
    Massin P; Lange C; Tichet J; Vol S; Erginay A; Cailleau M; Eschwège E; Balkau B;
    Arch Ophthalmol; 2011 Feb; 129(2):188-95. PubMed ID: 21320965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD Study. Risk Factors in Impaired Glucose Tolerance for Atherosclerosis and Diabetes.
    Hanefeld M; Koehler C; Henkel E; Fuecker K; Schaper F; Temelkova-Kurktschiev T
    Diabet Med; 2000 Dec; 17(12):835-40. PubMed ID: 11168325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. population: Implications for diabetes diagnostic thresholds.
    Cheng YJ; Gregg EW; Geiss LS; Imperatore G; Williams DE; Zhang X; Albright AL; Cowie CC; Klein R; Saaddine JB
    Diabetes Care; 2009 Nov; 32(11):2027-32. PubMed ID: 19875604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.